The MHRA has authorised rilzabrutinib for adults with ITP where prior therapies have failed, based on phase 3 data showing durable platelet response.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/mhra-authorises-rilzabrutinib-adult-itp-2026a1000ibk?src=rss
Author :
Publish date : 2026-06-02 17:43:00
Copyright for syndicated content belongs to the linked Source.
